What is the state of hyperimmune plasma treatment today? What are the initial results? And what role can it play in the near future, even in the event of a second wave of the pandemic? These questions and many others will be answered during the second episode of the live-streaming event "The gift of the Cured Versus the Pandemic", entitled "Plasma Arsenals: This is How we can tackle COVID Today (but above all, Tomorrow)." The appointment, which follows on from a similar live broadcast a month ago (April 16) on DonatoriH24.it to discuss the potential of plasma treatment, is scheduled for Wednesday, May 20 starting at 7 pm and is supported by Kedrion Biopharma with an unconditional contribution.
Five of the top national experts on the subject, all of whom are currently at the forefront of the fight against COVID-19, will participate in this new remote round table discussion: Francesco Menichetti, Infectologist, Director of the Infectious Diseases Unit of the Pisa AOU and Principal Researcher in the national Tsunami study on the effectiveness and role of COVID-19 convalescent plasma; Rosa Chianese, Head of the Regional Blood Center of the Lombardy Region; Pasquale Colamartino, Head of the Regional Blood Center of the Abruzzo Region; Gianpietro Briola, National President of Avis; and Alessandro Gringeri, Chief Medical and R&D Officer at Kedrion.
They will discuss the importance of having stocks of inactivated plasma, whose shelf life (four years) and standardization make it an anti-COVID drug to all effects; the role of donors, which is yet another determining factor; the next step in the fight against the Coronavirus: specific immunoglobulins.